257 related articles for article (PubMed ID: 22395730)
1. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
Ferris MJ; Calipari ES; Mateo Y; Melchior JR; Roberts DC; Jones SR
Neuropsychopharmacology; 2012 Jun; 37(7):1708-16. PubMed ID: 22395730
[TBL] [Abstract][Full Text] [Related]
2. Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.
Calipari ES; Ferris MJ; Siciliano CA; Jones SR
ACS Chem Neurosci; 2015 Jan; 6(1):155-62. PubMed ID: 25474655
[TBL] [Abstract][Full Text] [Related]
3. Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter.
Calipari ES; Ferris MJ; Siciliano CA; Zimmer BA; Jones SR
J Pharmacol Exp Ther; 2014 May; 349(2):192-8. PubMed ID: 24566123
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.
Calipari ES; Ferris MJ; Melchior JR; Bermejo K; Salahpour A; Roberts DC; Jones SR
Addict Biol; 2014 Mar; 19(2):145-55. PubMed ID: 22458761
[TBL] [Abstract][Full Text] [Related]
5. Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration.
Ferris MJ; Mateo Y; Roberts DC; Jones SR
Biol Psychiatry; 2011 Feb; 69(3):201-7. PubMed ID: 20801429
[TBL] [Abstract][Full Text] [Related]
6. Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.
Calipari ES; Jones SR
Neuropharmacology; 2014 Jul; 82():1-10. PubMed ID: 24632529
[TBL] [Abstract][Full Text] [Related]
7. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
Ukairo OT; Ramanujapuram S; Surratt CK
Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
[TBL] [Abstract][Full Text] [Related]
8. The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.
Gruner JA; Marcy VR; Lin YG; Bozyczko-Coyne D; Marino MJ; Gasior M
Sleep; 2009 Nov; 32(11):1425-38. PubMed ID: 19928382
[TBL] [Abstract][Full Text] [Related]
9. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
[TBL] [Abstract][Full Text] [Related]
10. A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration.
Ferris MJ; Calipari ES; Rose JH; Siciliano CA; Sun H; Chen R; Jones SR
Neuropsychopharmacology; 2015 Jul; 40(8):1826-36. PubMed ID: 25689882
[TBL] [Abstract][Full Text] [Related]
11. Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.
Walker QD; Morris SE; Arrant AE; Nagel JM; Parylak S; Zhou G; Caster JM; Kuhn CM
J Pharmacol Exp Ther; 2010 Oct; 335(1):124-32. PubMed ID: 20605908
[TBL] [Abstract][Full Text] [Related]
12. Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.
Siciliano CA; Fordahl SC; Jones SR
J Neurosci; 2016 Jul; 36(30):7807-16. PubMed ID: 27466327
[TBL] [Abstract][Full Text] [Related]
13. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Héron C; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
[TBL] [Abstract][Full Text] [Related]
14. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
Silvia CP; Jaber M; King GR; Ellinwood EH; Caron MG
Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
[TBL] [Abstract][Full Text] [Related]
15. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
Hiranita T; Soto PL; Kohut SJ; Kopajtic T; Cao J; Newman AH; Tanda G; Katz JL
J Pharmacol Exp Ther; 2011 Nov; 339(2):662-77. PubMed ID: 21859929
[TBL] [Abstract][Full Text] [Related]
16. Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter.
Calipari ES; Ferris MJ; Zimmer BA; Roberts DC; Jones SR
Neuropsychopharmacology; 2013 Nov; 38(12):2385-92. PubMed ID: 23719505
[TBL] [Abstract][Full Text] [Related]
17. Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.
Yorgason JT; Calipari ES; Ferris MJ; Karkhanis AN; Fordahl SC; Weiner JL; Jones SR
Neuropharmacology; 2016 Feb; 101():471-9. PubMed ID: 26525189
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.
Tella SR; Ladenheim B; Cadet JL
J Pharmacol Exp Ther; 1997 Apr; 281(1):508-13. PubMed ID: 9103538
[TBL] [Abstract][Full Text] [Related]
19. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys.
Kohut SJ; Jacobs DS; Rothman RB; Partilla JS; Bergman J; Blough BE
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3455-3465. PubMed ID: 28889212
[TBL] [Abstract][Full Text] [Related]
20. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation.
Mateo Y; Lack CM; Morgan D; Roberts DC; Jones SR
Neuropsychopharmacology; 2005 Aug; 30(8):1455-63. PubMed ID: 15702135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
